Low incidence of TEL/AML1 fusion and TEL deletion in Korean childhood acute leukemia by extra-signal fluorescence in situ hybridization

被引:24
作者
Park, KU
She, CJ
Shin, HY
Ahn, HS
Kim, CJ
Cho, BK
Cho, HI
Lee, DS
机构
[1] Seoul Natl Univ, Coll Med, Dept Clin Pathol, Chongno Gu, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Pediat, Chongno Gu, Seoul 110744, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Pathol, Chongno Gu, Seoul 110744, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Neurosurg, Chongno Gu, Seoul 110744, South Korea
关键词
D O I
10.1016/S0165-4608(00)00374-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TEAL/AML1 fusion in acute leukemia results from cryptic translocation of chromosome 12 and 21, the presence of which suggests a favorable prognosis. The incidence of TEL/AML1 fusion in B-lineage ALL is approximately 25%, but the incidence in Korea has not yet been reported. To investigate the incidence of TEL/AML1 fusion and TEL deletion, bone marrow specimens from 77 Korean children with newly diagnosed acute leukemia were analyzed by FISH. We applied extra-signal FISH to discriminate a true TEL/AML1 fusion from a false-positive fusion signal. To determine the cut-off value of the TEL/AML1 fusion signal, 20 normal bone marrow specimens and 28 normal peripheral blood specimens were also analyzed. The frequency of patients with TEL/AML1 fusion was 13.3% (4 cases) among 30 B-lineage ALL and 9.5% among 42 ALL. One TEL/AML1 fusion-positive patient was also found among 4 acute biphenotypic leukemias. TEL/AML1 fusion was not found in any samples from patients with T-lineage ALL or AML. The incidence of TEL deletion was 6.7% (2 cases) among 30 B-lineage ALL and 4.8% among 42 ALL. The incidences of TEL/AML1 fusion and TEL deletion in Korean children with acute leukemia appear to be lower than those in other countries, suggesting a racial difference. (C) 2001 Elsevier Science Inc., All rights reserved.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 24 条
  • [11] Mitelman F, 1995, ISCN INT SYSTEM HUMA
  • [12] CHARACTERIZATION OF CHILDHOOD ACUTE-LEUKEMIA WITH MULTIPLE MYELOID AND LYMPHOID MARKERS AT DIAGNOSIS AND AT RELAPSE
    PUI, CH
    RAIMONDI, SC
    HEAD, DR
    SCHELL, MJ
    RIVERA, GK
    MIRRO, J
    CRIST, WM
    BEHM, FG
    [J]. BLOOD, 1991, 78 (05) : 1327 - 1337
  • [13] RAIMONDI SC, 1986, BLOOD, V68, P69
  • [14] RAIMONDI SC, 1993, BLOOD, V81, P2237
  • [15] Raynaud S, 1996, LEUKEMIA, V10, P1529
  • [16] HIGH-FREQUENCY OF T(12-21) IN CHILDHOOD B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA
    ROMANA, SP
    POIREL, H
    LECONIAT, M
    FLEXOR, MA
    JONVEAUX, MMP
    MACINTYRE, EA
    BERGER, R
    BERNARD, OA
    [J]. BLOOD, 1995, 86 (11) : 4263 - 4269
  • [17] Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL and ETV6 gene abnormalities: results of St Jude total therapy study XII
    Rubnitz, JE
    Behm, FG
    Pui, CH
    Evans, WE
    Relling, MV
    Raimondi, SC
    Harrison, PL
    Sandlund, JT
    Ribeiro, RC
    Grosveld, G
    Downing, JR
    [J]. LEUKEMIA, 1997, 11 (08) : 1201 - 1206
  • [18] TEL gene rearrangement in acute lymphoblastic leukemia: A new genetic marker with prognostic significance
    Rubnitz, JE
    Downing, JR
    Pui, CH
    Shurtleff, SA
    Raimondi, SC
    Evans, WE
    Head, DR
    Crist, WM
    Rivera, GK
    Hancock, ML
    Boyett, JM
    Buijs, A
    Grosveld, G
    Behm, FG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1150 - 1157
  • [19] Shih LY, 1996, LEUKEMIA, V10, P1456
  • [20] Shurtleff SA, 1995, LEUKEMIA, V9, P1985